0001752724-21-193804.txt : 20210909
0001752724-21-193804.hdr.sgml : 20210909
20210909104953
ACCESSION NUMBER: 0001752724-21-193804
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210630
FILED AS OF DATE: 20210909
DATE AS OF CHANGE: 20210909
EFFECTIVENESS DATE: 20210909
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MFS SERIES TRUST XVI
CENTRAL INDEX KEY: 0000063067
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-02032
FILM NUMBER: 211243800
BUSINESS ADDRESS:
STREET 1: 111 HUNTINGTON AVENUE
STREET 2: 24TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02199
BUSINESS PHONE: 18006372929
MAIL ADDRESS:
STREET 1: 111 HUNTINGTON AVENUE
STREET 2: 24TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02199
FORMER COMPANY:
FORMER CONFORMED NAME: MFS GROWTH OPPORTUNITIES FUND
DATE OF NAME CHANGE: 19940304
FORMER COMPANY:
FORMER CONFORMED NAME: MFS CAPITAL DEVELOPMENT FUND
DATE OF NAME CHANGE: 19930408
FORMER COMPANY:
FORMER CONFORMED NAME: MASSACHUSETT MFS CAPITAL DEVELOPMENT FUND
DATE OF NAME CHANGE: 19921015
0000063067
S000059884
MFS Prudent Investor Fund
C000195901
A
FPPAX
C000195903
B
FPPDX
C000195904
C
FPPEX
C000195905
I
FPPJX
C000195906
R1
FPPRX
C000195907
R2
FPPSX
C000195908
R3
FPPQX
C000195909
R4
FPPUX
C000195910
R6
FPPVX
N-CEN
1
primary_doc.xml
X0404
N-CEN
LIVE
0000063067
XXXXXXXX
811-02032
true
false
false
N-1A
true
MFS Series Trust XVI
811-02032
0000063067
5493008WCCG2JFMV6Z59
111 Huntington Avenue
Boston
02199
US-MA
US
617-954-5000
Charles River Development
700 District Avenue
Burlington
01803
17812380099
Investment related records
Institutional Shareholder Services Inc.
702 King Farm Boulevard Suite 400
Rockville
20850
13015560500
Proxy voting administrator
The Depository Trust Company
55 Water Street
New York
10041
12128551000
DTC
JPMorgan Chase
270 Park Avenue
New York
10017
12122706000
Custodian record
Iron Mountain Inc.
1 Federal Street
Boston
02110
18008994766
Storage Vendor
DST Systems,Inc.
333 West 11thStreet
Kansas City
64105
18164351000
Technology Vendor
MFS Service Center Inc.
100 Hancock Street
North Quincy
02171
16179545000
Transfer agency record
MFS Fund Distributors,Inc.
111 Huntington Avenue
Boston
02199
16179545000
Principal underwriter record
Ropes&Gray
800 Boylston Street
Boston
02199
16179517000
Counsel record
TerraNua U.S. Corp d.b.a. My Compliance Office
535 5th Avenue 4th floor
New York
10017
18669512280
Personal Trading System
Autonomy Corporation Limited
1140 Enterprise Way
Sunnyvale
94089
441223448000
Storage Vendor
Massachusetts Financial Services Company
111 Huntington Avenue
Boston
02199
16179545000
Investment adviser record
N
N
N-1A
1
Y
John A. Caroselli
N/A
N
Maureen R. Goldfarb
N/A
N
Laurie J. Thomsen
N/A
N
Maryanne L. Roepke
N/A
N
Clarence Otis, Jr.
N/A
N
Robert J. Manning
004646484
Y
James W. Kilman, Jr.
N/A
N
Michael W. Roberge
N/A
Y
Peter D. Jones
N/A
N
Steven E. Buller
N/A
N
John P. Kavanaugh
N/A
N
Martin J. Wolin
004331075
111 Huntington Avenue
Boston
02199
XXXXXX
N
N
N
N
N
N
N
MFS FUND DISTRIBUTORS, INC.
8-45321
000031052
N/A
Y
N
DELOITTE & TOUCHE LLP
34
N/A
N
N
N
N
N
N
MFS Prudent Investor Fund
S000059884
549300GL4THNMBUGZH54
N
9
0
0
N/A
N
N
Y
N
N
JPMorgan Chase Bank N.A.
8I5DZWZKVSZI1NUHU748
N
N
Revenue sharing split
Cash collateral reinvestment fee
19427.91000000
75.29000000
Rule 32a-4 (17 CFR 270.32a-4)
Rule 12d1-1 (17 CFR 270.12d1-1)
Rule 22d-1 (17 CFR 270.22d-1)
Y
Y
N
N
MASSACHUSETTS FINANCIAL SERVICES COMPANY
801-17352
000110045
1G3OSH3GLGJ7X1JC5I61
N
MFS SERVICE CENTER, INC.
84-1316
N/A
Y
N
N
ICE Data Pricing & Reference Data, LLC
5493000NQ9LYLDBCTL34
N
Refinitiv U.S. Holdings Inc.
5490300NF240HXJO7N016
N
IHS Markit
549300HLPTRASHS0E726
GB
N
N
JPMORGAN CHASE BANK
7H6GLXDRUGQFU57RNE97
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
MFS Service Center, Inc.
084-01316
SEC identifier
Y
N
N
MASSACHUSETTS FINANCIAL SERVICES
1G3OSH3GLGJ7X1JC5I61
Y
N
N
Morgan Stanley & Co. LLC
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
424.30000000
Berenberg Capital Markets LLC
8-68821
000156757
5493007EG0CYRKKG9L11
299.81000000
Citigroup Global Markets Inc.
8-08177
000007059
MBNUM2BPBDO7JBLYG310
670.91000000
Merrill Lynch, Pierce, Fenner & Smith Inc.
8-07221
000007691
8NAV47T0Y26Q87Y0QP81
777.52000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
550.23000000
BofA Securities, Inc.
8-69787
000283942
549300HN4UKV1E2R3U73
264.79000000
Jefferies LLC
8-15074
000002347
58PU97L1C0WSRCWADL48
637.21000000
Credit Suisse Securities (USA) LLC
8-00422
000000816
1V8Y6QCX6YMJ2OELII46
299.58000000
Goldman Sachs & Co. LLC
8-00129
000000361
FOR8UP27PHTHYVLBNG30
624.46000000
BNP Paribas Securities Corp.
8-32682
000015794
RCNB6OTYUAMMP879YW96
583.16000000
6702.61000000
Wells Fargo Securities, LLC
8-65876
000126292
VYVVCKR63DVZZN70PB21
669315.84000000
Nomura Securities International, Inc.
8-15255
000004297
OXTKY6Q8X53C9ILVV871
531617.97000000
BNP Paribas Securities Corp.
8-32682
000015794
RCNB6OTYUAMMP879YW96
921722.44000000
Societe Generale
N/A
N/A
O2RNE8IBXP4R0TD8PU41
FR
1210595.65000000
Goldman Sachs & Co. LLC
8-00129
000000361
FOR8UP27PHTHYVLBNG30
821544.89000000
Citigroup Global Markets Inc.
8-08177
000007059
MBNUM2BPBDO7JBLYG310
3481030.08000000
Deutsche Bank Securities Inc.
8-17822
000002525
9J6MBOOO7BECTDTUZW19
2997864.28000000
BofA Securities, Inc.
8-69787
000283942
549300HN4UKV1E2R3U73
702261.50000000
Morgan Stanley & Co. LLC
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
2230825.82000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
3700911.22000000
18800386.63000000
Y
45837736.79000000
Uncommitted
200000000.00000000
N
Uncommitted
100000000.00000000
N
Committed
1250000000.00000000
N
N
N
N
false
false
true
false
false
false
INTERNAL CONTROL RPT
2
Audit_Letter_Series_Trust.txt
AUDIT LETTER
REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM
To the Board of Trustees of MFS Series Trust XVI and the
Shareholders of MFS Prudent Investor Fund:
In planning and performing our audit of the financial
statements of MFS Prudent Investor Fund (the Fund)
as of and for the year ended June 30, 2021, in accordance
with the standards of the Public Company Accounting
Oversight Board (United States), we considered the Funds
internal control over financial reporting, including controls
over safeguarding securities, as a basis for designing our
auditing procedures for the purpose of expressing our opinions
on the financial statements and to comply with the requirements
of Form N-CEN, but not for the purpose of expressing an opinion
on the effectiveness of the Funds internal control over
financial reporting. Accordingly, we express no such opinion.
The management of the Fund is responsible for establishing and
maintaining effective internal control over financial reporting.
In fulfilling this responsibility, estimates and judgments by
management are required to assess the expected benefits and
related costs of controls. A funds internal control over
financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles.
A funds internal control over financial reporting includes
those policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions
and dispositions of the assets of the fund;
(2) provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial
statements in accordance with generally accepted
accounting principles, and that receipts and expenditures
of the fund are being made only in accordance with authorizations
of management of the fund and trustees of the trust; and
(3) provide reasonable assurance regarding prevention or
timely detection of unauthorized acquisition, use, or
disposition of a funds assets that could have a material
effect on the financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions or that the degree
of compliance with the policies or procedures may deteriorate.
A deficiency in internal control over financial reporting exists
when the design or operation of a control does not allow
management or employees, in the normal course of performing
their assigned functions, to prevent or detect misstatements
on a timely basis. A material weakness is a deficiency,
or a combination of deficiencies, in internal control over
financial reporting, such that there is a reasonable possibility
that a material misstatement of a funds annual or interim
financial statements will not be prevented or detected on a
timely basis. Our consideration of the Funds internal control
over financial reporting was for the limited purpose described
in the first paragraph and would not necessarily disclose all
deficiencies in internal control that might be material
weaknesses under standards established by the Public
Company Accounting Oversight Board (United States). However, we
noted no deficiencies in the Funds internal control over
financial reporting and its operations, including controls for
safeguarding securities, that we consider to be a material
weakness, as defined above, as of June 30, 2021. This report is
intended solely for the information and use of management,
the Board of Trustees of MFS Series Trust XVI and the Securities
and Exchange Commission and is not intended to be and should not
be used by anyone other than these specified parties.
DELOITTE & TOUCHE LLP
Boston, Massachusetts
August 13, 2021